| Amylin | |
| Deficiency | Type 1, type 2 diabetes |
| Site of synthesis | Pancreatic beta cells |
| Glucose-dependent stimulation of insulin secretion | No |
| Reduction of gastric emptying | Yes |
| Reduction of inappropriate glucagon secretion | Yes |
| Weight loss | Yes |
| Beta cell proliferation/regeneration | Unknown |
| Therapies | Pramlintide (Symlin) |
| Target population | Type 1 diabetes and insulin-treated type 2 diabetes |
